Solace Stress Urinary inContinence Control Efficacy and Safety Study

NCT02210273 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
221
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Solace Therapeutics, Inc.